Thomas Kohnke (Thomas Köhnke)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Topics

Acute Myeloid Leukemia

Hematopoietic Stem Cell

Helicobacter Pylori Infection

Top Venues

Blood cancer discovery

Cancer discovery

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Kohnke, Kevin A Nuno, Catherine C Alder, Eric J Gars, Paul Phan, Amy C Fan, Ravindra Majeti
Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119. Blood cancer discovery 5 (3) (2024)
Thomas Kohnke, Kevin A Nuno, Catherine C Alder, Eric J Gars, Paul Phan, Amy C Fan, Ravindra Majeti
Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119. Blood cancer discovery 5 (3) (2024)
Thomas Kohnke, Kevin A Nuno, Catherine C Alder, Eric J Gars, Paul Phan, Amy C Fan, Ravindra Majeti
Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119. Blood cancer discovery 5 (3) (2024)
Thomas Kohnke, Kevin A Nuno, Catherine C Alder, Eric J Gars, Paul Phan, Amy C Fan, Ravindra Majeti
Human ASXL1-mutant hematopoiesis is driven by a truncated protein associated with aberrant de-ubiquitination of H2AK119. Blood cancer discovery (2024)
Niklas Landberg, Thomas Kohnke, Yang Feng, Yusuke Nakauchi, Amy C Fan, Miles H Linde, Daiki Karigane, Kelly Lim, Rahul Sinha, Luca Malcovati, Daniel Thomas, Ravindra Majeti
IDH1-Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation. Blood cancer discovery (2024)
Niklas Landberg, Thomas Kohnke, Yang Feng, Yusuke Nakauchi, Amy C Fan, Miles H Linde, Daiki Karigane, Kelly Lim, Rahul Sinha, Luca Malcovati, Daniel Thomas, Ravindra Majeti
IDH1-mutant preleukemic hematopoietic stem cells can be eliminated by inhibition of oxidative phosphorylation. Blood cancer discovery (2023)
Miles H Linde, Amy C Fan, Thomas Kohnke, Aaron C Trotman-Grant, Sarah F Gurev, Paul Phan, Feifei Zhao, Naomi L Haddock, Kevin A Nuno, Eric J Gars, Melissa Stafford, Payton L Marshall, Christopher G Dove, Ian L Linde, Niklas Landberg, Lindsay P Miller, Robbie G Majzner, Tian Yi Zhang, Ravindra Majeti
Reprogramming Cancer into Antigen Presenting Cells as a Novel Immunotherapy. Cancer discovery (2023)
Daniel Thomas, Manhong Wu, Yusuke Nakauchi, Ming Zheng, Chloe A L Thompson-Peach, Kelly Lim, Niklas Landberg, Thomas Kohnke, Nirmal Robinson, Satinder Kaur, Monika M Kutyna, Melissa Stafford, Devendra K Hiwase, Andreas Reinisch, Gary Peltz, Ravindra Majeti
Dysregulated lipid synthesis by oncogenic IDH1 mutation is a targetable synthetic lethal vulnerability. Cancer discovery (2022)
Thomas Kohnke, Veronika K Wittmann, Veit L Bücklein, Felix S Lichtenegger, Zlatana Pasalic, Wolfgang Hiddemann, Karsten Spiekermann, Marion Subklewe
Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200. British journal of haematology 179 (3) (2017)